Cancer clinical trials are vital for improving treatments. Clinical trial decision-making has been examined from the perspectives of patients and oncologists, but caregiver perspectives on clinical trials and roles in patient enrollment decisions remain understudied.
Methods
This scoping review assessed the state of current research on caregiver roles in cancer trial enrollment decision-making. A review of empirical literature was conducted in January 2024 using PubMed and Embase. Articles were evaluated using a review instrument to determine the aspect of decision-making evaluated, the roles of caregivers in clinical trial enrollment decision-making, and recommendations based on study results.
Results
A total of 23 articles were included in the review. Studies focused on awareness and attitudes about clinical trials (7 articles), hypothetical willingness to participate in a trial (6 articles), and experiences with decision-making (10 articles). Caregiver roles included supporting and deferring to patient autonomy, communicating with clinicians, and taking on burden to facilitate participation in the trial. Researchers recommended including caregivers in clinical trial enrollment discussions and educational outreach, developing interventions to reduce caregiver burden, and future research on caregiver clinical trial decision-making using the framework of relational autonomy.
Conclusion
Empirical research on caregiver roles in clinical trial enrollment decision-making is limited. Findings of this review suggest that caregivers experience tension between their perceived role of supporting the patient’s autonomy and their own well-being. More research is needed to understand how caregivers navigate these challenges and identify best practices for their inclusion in clinical trial consent.
KentEERowlandJHNorthouseL, et al. Caring for caregivers and patients: research and clinical priorities for informal cancer caregiving. Cancer2016; 122: 1987–1995.
2.
RezashVReedJGedeonB, et al. Who needs what? Perceptions of patients and caregivers in oncology phase 1 trials. J Patient Exp2020; 7(1): 27–33.
3.
KesslerERMossAEckhardtSG, et al. Distress among caregivers of phase I trial participants: a cross-sectional study. Support Care Cancer2014; 22(12): 3331–3340.
4.
UngerJMHershmanDLTillC, et al. “When offered to participate”: a systematic review and meta-analysis of patient agreement to participate in cancer clinical trials. J Natl Cancer Inst2021; 113: 244–257.
5.
SedrakMSMohileSGSunV, et al. Barriers to clinical trial enrollment of older adults with cancer: a qualitative study of the perceptions of community and academic oncologists. J Geriatr Oncol2020; 11(2): 327–334.
6.
Dionne-OdomJNKentEERocqueGB, et al. Family caregiver roles and challenges in assisting patients with cancer treatment decision-making: analysis of data from a national survey. Health Expect2023; 26(5): 1965–1976.
7.
YennurajalingamSRodriguesLFShamiehOM, et al. Decisional control preferences among patients with advanced cancer: an international multicenter cross-sectional survey. Palliat Med2018; 32(4): 870–880.
8.
Dionne-OdomJNEjemDWellsR, et al. How family caregivers of persons with advanced cancer assist with upstream healthcare decision-making: a qualitative study. PLoS ONE2019; 14(3): e0212967.
9.
ArkseyHO’MalleyL.Scoping studies: towards a methodological framework. Int J Soc Res Methodol2005; 8: 19–32.
10.
HlubockyFJSherTGCellaD, et al. Anxiety shapes expectations of therapeutic benefit in phase i trials for patients with advanced cancer and spousal caregivers. JCO Oncol Pract2021; 17(2): e101–e110.
11.
BazarbashiSHassanAEldinAM, et al. Awareness and perceptions of clinical trials in cancer patients and their families in Saudi Arabia. J Cancer Educ2015; 30(4): 655–659.
12.
AsieduGBRidgewayJLCarrollK, et al. “Ultimately, mom has the call”: viewing clinical trial decision making among patients with ovarian cancer through the lens of relational autonomy. Health Expect2018; 21(6): 981–989.
13.
BibbyACMorleyAJKeenanE, et al. The priorities of people with mesothelioma and their carers: a qualitative interview study of trial participation and treatment decisions. Eur J Oncol Nurs2022; 57: 102111.
14.
EngebretsonAMatrisianLThompsonC.Patient and caregiver awareness of pancreatic cancer treatments and clinical trials. J Gastrointest Oncol2016; 7(2): 228–233.
15.
Flood-GradyENeilJMPaigeSR, et al. A pilot study determining comprehension and the acceptability of a cancer research study website for cancer patients and caregivers. J Cancer Educ2020; 35(3): 589–598.
16.
GinossarTDiaz FuentesCOetzelJ.Understanding willingness to participate in cancer clinical trials among patients and caregivers attending a minority-serving academic cancer center. J Cancer Educ2022; 37(1): 179–187.
17.
Granda-CameronCMcLean FlorenceYWhitfield-HarrisL, et al. Perceptions of clinical trial participation in African American cancer survivors and caregivers. Oncol Nurs Forum2022; 49: 113–124.
18.
Haynes-MaslowLGodleyPDimartinoL, et al. African American women’s perceptions of cancer clinical trials. Cancer Med2014; 3: 1430–1439.
19.
KoganNTolleyMCohenR.Family caregivers support their patient’s decision to participate in a phase 1 clinical trial: weighing the pros and cons, bearing the costs. Psychooncology2022; 31(8): 1374–1380.
20.
KriegerJL.Last resort or roll of the die? Exploring the role of metaphors in cancer clinical trials education among medically underserved populations. J Health Commun2014; 19: 1161–1177.
21.
MokhnatkinJVBaeMDaleW, et al. Facilitators and barriers to older adult participation in cancer trials: a qualitative study exploring patient-caregiver dyad congruence. JCO Oncol Pract2023; 19(7): 484–492.
22.
PaidipatiCPFoxwellAMMooney-DoyleK, et al. Caregiver perspectives on the benefits, burdens, and moral distress of participation in cancer clinical trials. J Fam Nurs2023; 29(1): 89–98.
23.
QuinnGPBell-EllisonBABellMY, et al. A message of hope: creation of the faces of lung cancer project for increasing awareness of clinical trials. Eur J Cancer Care2008; 17(6): 601–610.
24.
QuinnGPMcIntyreJGonzalezLE, et al. Improving awareness of cancer clinical trials among Hispanic patients and families: audience segmentation decisions for a media intervention. J Health Commun2013; 18(9): 1131–1147.
25.
Radecki BreitkopfCRidgewayJLAsieduGB, et al. Ovarian cancer patients’ and their family members’ perspectives on novel vaccine and virotherapy trials. Clin Trials2016; 13(6): 660–664.
26.
RidgewayJLAsieduGBCarrollK, et al. Patient and family member perspectives on searching for cancer clinical trials: a qualitative interview study. Patient Educ Couns2017; 100(2): 349–354.
27.
SalemRMatarCAssiR, et al. Perceptions and attitudes of cancer patients and caregivers towards enrollment in clinical trials in Lebanon. J Cancer Educ2019; 34(2): 334–338.
28.
Shannon-DorcyKDrevdahlDJ.“I had already made up my mind”: patients and caregivers’ perspectives on making the decision to participate in research at a US cancer referral center. Cancer Nurs2011; 34(6): 428–433.
29.
ShinDWChoJKimSY, et al. Attitudes toward participating in phase I clinical trials: an investigation with patient-family-physician triads. Jpn J Clin Oncol2016; 46(12): 1095–1101.
30.
TranthamLCCarpenterWRDiMartinoLD, et al. Perceptions of cancer clinical research among African American men in North Carolina. J Natl Med Assoc2015; 107(1): 33–41.
31.
VasquezTSEgglySSae-HauM, et al. Preparing patients to communicate with their doctors about clinical trials as a treatment option: impact of a novel video intervention for patients with a blood cancer and their caregivers. J Cancer Educ2023; 38(5): 1562–1570.
32.
WellsKJQuinnGPMeadeCD, et al. Development of a cancer clinical trials multi-media intervention: clinical trials: are they right for you. Patient Educ Couns2012; 88(2): 232–240.
33.
LargentEAKarlawishJGrillJD.Study partners: essential collaborators in discovering treatments for Alzheimer’s disease. Alzheimers Res Ther2018; 10: 101.
34.
BlackBSTaylorHARabinsPV, et al. Study partners perform essential tasks in dementia research and can experience burdens and benefits in this role. Dementia. Epub ahead of print 13 May 2016. DOI: 10.1177/1471301216648796.
35.
LargentEAClappJBlumenthal-BarbyJS, et al. Deciding with others: interdependent decision-making. Hastings Cent Rep2022; 52(6): 23–32.
36.
CamererCMobbsD.Differences in behavior and brain activity during hypothetical and real choices. Trends Cogn Sci2017; 21(1): 46–56.
37.
PatelVLKaufmanDRArochaJF.Emerging paradigms of cognition in medical decision-making. J Biomed Inform2002; 35(1): 52–75.
38.
WeissDMNorthouseLLDuffySA, et al. Qualitative analysis of the experience of mental fatigue of family caregivers of patients with cancer in phase I trials. Oncol Nurs Forum2016; 43: E153–E160.
39.
HoA.Relational autonomy or undue pressure? Family’s role in medical decision-making. Scand J Caring Sci2008; 22: 128–135.
40.
DonchinA.Understanding autonomy relationally: toward a reconfiguration of bioethical principles. J Med Philos2001; 26(4): 365–386.
41.
ShepherdVHoodKSheehanM, et al. Ethical understandings of proxy decision making for research involving adults lacking capacity: a systematic review (framework synthesis) of empirical research. AJOB Empir Bioeth2018; 9(4): 267–286.
42.
UllrichATheochariMBergeltC, et al. Ethical challenges in family caregivers of patients with advanced cancer—a qualitative study. BMC Palliat Care2020; 19: 70.
